At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Jane Apperley, MD from Imperial College London, London, UK discusses developments leading to gene therapies for the management of graft-versus-host-disease (GvHD) and CAR T-cells designed specifically for Acute Myeloid Leukemia (AML) and Myeloma.